1.51
price down icon2.58%   -0.04
after-market After Hours: 1.50 -0.01 -0.66%
loading
Sunshine Biopharma Inc stock is traded at $1.51, with a volume of 160.82K. It is down -2.58% in the last 24 hours and down -29.11% over the past month. Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$1.55
Open:
$1.51
24h Volume:
160.82K
Relative Volume:
0.12
Market Cap:
$4.69M
Revenue:
$32.96M
Net Income/Loss:
$-4.23M
P/E Ratio:
-0.00972
EPS:
-155.3294
Net Cash Flow:
$-14.00M
1W Performance:
+20.80%
1M Performance:
-29.11%
6M Performance:
-50.00%
1Y Performance:
-90.65%
1-Day Range:
Value
$1.45
$1.57
1-Week Range:
Value
$1.21
$1.60
52-Week Range:
Value
$1.1693
$23.80

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Name
Name
Sunshine Biopharma Inc
Name
Phone
954-515-0810
Name
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Name
Employee
52
Name
Twitter
Name
Next Earnings Date
2025-04-08
Name
Latest SEC Filings
Name
SBFM's Discussions on Twitter

Compare SBFM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
SBFM
Sunshine Biopharma Inc
1.51 4.69M 32.96M -4.23M -14.00M -155.33
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.47 65.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 46.99B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.18 45.96B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.87 17.04B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
291.38 12.77B 2.76B 1.11B 898.10M 22.77

Sunshine Biopharma Inc Stock (SBFM) Latest News

pulisher
Apr 24, 2025

There is no doubt that Sunshine Biopharma Inc (SBFM) ticks all the boxes. - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Sunshine Becomes Latest To Compete On Everolimus In Canada - insights.citeline.com

Apr 23, 2025
pulisher
Apr 22, 2025

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug - NewsBreak: Local News & Alerts

Apr 22, 2025
pulisher
Apr 21, 2025

Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug By Stocktwits - Investing.com India

Apr 21, 2025
pulisher
Apr 21, 2025

SBFM Stock: A Comprehensive Analysis and Forecast - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025
pulisher
Apr 21, 2025

SBFM’s valuation metrics: A comprehensive analysis - uspostnews.com

Apr 21, 2025
pulisher
Apr 21, 2025

Sunshine Biopharma (SBFM) Finalizes $2.46 Million Stock Offering - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Sunshine Biopharma enters Canadian generic drug market with Everolimus - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada | SBFM Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion | SBFM Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Major Cancer Treatment Everolimus Enters Canadian Market: Multiple Cancer Types Targeted in $2.5B Opportunity - Stock Titan

Apr 21, 2025
pulisher
Apr 16, 2025

Sunshine Biopharma stock hits 52-week low at $1.24 - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

Sunshine Biopharma stock hits 52-week low at $1.24 By Investing.com - Investing.com India

Apr 16, 2025
pulisher
Apr 04, 2025

Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 10.9% – Here’s Why - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Sunshine Biopharma Secures $2.46 Million in Direct Offering - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Sunshine Biopharma Closes $2.5 Million Direct Offering - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 03, 2025

SEC Form 424B5 filed by Sunshine Biopharma Inc. - Quantisnow

Apr 03, 2025
pulisher
Apr 03, 2025

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Sunshine Biopharma’s K1.1-mRNA-LNP shows promise in HCC mouse model - BioWorld MedTech

Apr 03, 2025
pulisher
Apr 03, 2025

The time has not yet come to remove your chips from the table: Sunshine Biopharma Inc (SBFM) - Sete News

Apr 03, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma secures $2.46 million in stock offering By Investing.com - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022 - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma (SBFM) Reports Increased Revenue Despite Net Loss - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma (SBFM) Secures $2.46 Million in Direct Stock Offering - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma secures $2.46 million in stock offering - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Biotech Stock Sunshine Biopharma Inc. (NASDAQ:SBFM) Makes NASDAQ Top Gainer List on News - Investorideas.com

Apr 02, 2025
pulisher
Apr 02, 2025

This Pharma Stock Is Gaining Major Steam Ahead Of Opening Bell - The Globe and Mail

Apr 02, 2025
pulisher
Apr 02, 2025

From Underdog to Top Performer: Sunshine Biopharma’s Impressive Surge - timothysykes.com

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma (SBFM) Announces Promising Results for Liver Cancer Treatment - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma reports progress in liver cancer treatment - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews

Apr 02, 2025
pulisher
Apr 02, 2025

Revolutionary mRNA Treatment Succeeds Against Deadly Liver Cancer in Latest Trial - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

Sunshine Biopharma (SBFM) Reports 2024 Financial Highlights - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Sunshine Biopharma Reports Record Revenue: 13 New Drugs and Cancer Treatment Breakthrough - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Sunshine Biopharma Inc. SEC 10-K Report - TradingView

Apr 01, 2025
pulisher
Mar 28, 2025

Sunshine Biopharma Inc expected to post earnings of 11 cents a shareEarnings Preview - TradingView

Mar 28, 2025
pulisher
Mar 25, 2025

Sunshine Biopharma signs agreement for rights to market two generic antibiotics - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

Sunshine Biopharma to market new antibiotics in Canada By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada - MSN

Mar 24, 2025
pulisher
Mar 24, 2025

Sunshine Biopharma to market new antibiotics in Canada - Investing.com India

Mar 24, 2025

Sunshine Biopharma Inc Stock (SBFM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$9.46
price up icon 0.00%
$27.84
price up icon 0.61%
$101.77
price down icon 1.80%
$8.13
price up icon 1.25%
$106.73
price up icon 0.92%
$291.38
price down icon 1.70%
Cap:     |  Volume (24h):